ARQT R&D to Revenue

Arcutis Biotherapeutics Inc · R&D to Revenue

ARQT logo

ARQT R&D to Revenue

Latest reported20.49%
ARQT FY R&D/Revenue (0.00% → 20.49%)
High-resolution chart · PNG

ARQT r&d to revenue history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Arcutis Biotherapeutics Inc R&D to Revenue — Annual fiscal periods
Period endingR&D to Revenue
20.4884%
38.8823%
185.5098%
4,949.4031%
0%
0%
0%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.